SCHEMBL30118267

SCHEMBL30118267

Cc1ccc2c(c1)c1cc(-c3nc(-c4ccc5c(c4)c4cc(C)ccc4n5-c4cc(-c5ccccc5)nc(-c5ccccc5)n4)nc(-c4ccc5c(c4)c4cc(C)ccc4n5-c4cc(-c5ccccc5)nc(-c5ccccc5)n4)n3)ccc1n2-c1cc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.45
▸ NPSR1 Q6W5P4 3/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ HPGD P15428 7/20 0.44
▸ KMT2A Q03164 9/20 0.43
▸ ALDH1A1 P00352 8/20 0.43
▸ MEN1 O00255 8/20 0.43
▸ KDM4E B2RXH2 6/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NTSR1 P30989 1/20 0.40
▸ THRB P10828 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ AGTR1 P30556 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ ADORA2A P29274 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21069180 1.00 MAPT (0.45) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL30118226 1.00 MAPT (0.45) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL21069133 0.89 MAPT (0.49) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL30118213 0.89 MAPT (0.49) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL15025826 0.89 ADORA3 (0.41) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL21069159 0.88 MAPT (0.48) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL30118250 0.88 MAPT (0.48) MAPTNPSR1HSD17B10TSHRMAPK1
SCHEMBL21068609 0.87 MEN1 (0.47) MAPTNPSR1HSD17B10MAPK1HPGD
SCHEMBL30118251 0.87 MEN1 (0.47) MAPTNPSR1HSD17B10MAPK1HPGD
SCHEMBL21965147 0.87 MAPT (0.49) MAPTNPSR1HSD17B10TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11575088-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-02-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11575088-B2 Composition of matter for use in organic light-emitting diodes CRY2, CYBA, ALDH1A2 MAPT 159/4885NPSR1 3026/4885HSD17B10 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback